Close Menu

NEW YORK (GenomeWeb) – Holzgerlingen, Germany-based Curetis said today that it has entered into an exclusive long-term strategic distribution partnership with A. Menarini Diagnostics.

Under the agreement, Florence, Italy-based Menarini will immediately begin distributing Curetis' products in Germany, France, Benelux, the UK, and Switzerland, markets to which Curetis had previously sold directly. From the second quarter, Menarini will be the exclusive distributor of Curetis' products in Italy, Spain, and Portugal, where local companies have been distributors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.